Professional Documents
Culture Documents
S. No Content Annexure
1 CFE Copy Enclosure -I
2 CFO Copy Enclosure -II
3 Land Documents Enclosure-III
COPY OF CFE
COPY OF CFO
LAND DOCUMENT
LIST OF ANNEXURES
S. No Content Annexure
1 List of Products Annexure-I
2 Manufaturing Process Description Annexure-II
3 Water Consumption Details Annexure-III
4 Hazardous waste
5 Industrial Process waste
Annexure-IV
6 Sewage sludge
7 Hazardous & Solid waste
8 Stack Emission Details Annexure-V
9 Process Emission Details Annexure-VI
10 List of Raw Materials Annexure- VII
Annexure - I
N,N-Dimethyl propyl
12 - Drug Intermediate 20000.00
magnesium chloride
Proton pump
13 Omeprazole 73590-58-6 20000.00
inhibitor.
Gastric Acid
14 Pantoprazole sodium 138786-67-1 Secretion 15000.00
Inhibitor
100-59-4
Organic
15 Phenyl magnesium chloride 15000.00
Reagents
16 Quetiapine Fumarate 111974-72-2 Antipsychotic, 5000.00
Gastric Acid
17 Rabeprazole Sodium 117976-90-6 Secretion 5000.00
Inhibitor
18 Sodium Methoxide 124-41-4 Antineoplastic 50000.00
19 Sodium tert butoxide 865-48-5 Organic Reagent 20000.00
20 Telmisartan 144701-48-4 Anti hypertensive 3000.00
Total 295000.00
Annexure - II
MANUFACTURING PROCESS
Process Description:
Stage-1
Magnesium metal is charged into a clean and dry reactor under nitrogen purging.
Charge DEE & THF and start stirring. Raise the reactor temperature up to required
temperature. Start and continue the addition of benzyl chloride up to completion of the
reaction. Distill off DEE and maintain for few hours and then cool to room temperature.
Check the sample and unload the material into the containers under nitrogen
atmosphere.Check the Product and unload the material into the containers under
Nitrogen atmosphere.
Route of synthesis:
Stage-1:
MgCl
Cl
THF
Mg +
Flow Chart:
Magnesium
Benzyl chloride Diethyl ether Rec
Stage-1
Diethyl ether THF Rec
Tetrahydrofuran
Material Balance:
Process Description
Stage-1
Magnesium metal is charged into a clean and dry reactor under nitrogen purging.
Charge THF and start stirring. Raise the reactor temperature up to required
temperature. Start and continue the addition of butyl chloride up to completion of the
reaction. Maintain for few hours and cool to room temperature. Check the Products and
unload the material into the containers under Nitrogen atmosphere.
Route of Synthesis
Stage-1
Nitrogen Mg CH3
Mg + Cl CH3 Cl
THF
Butyl Magnesium Chloride
Magnesium Butyl chloride
C4H9MgCl
24.31 C4H9Cl
92.57 116.87
Flow Chart
Magnesium Metal
Butyl Chloride Stage-1 THF Rec
THF
Material Balance:
3. DOMPERIDONE
Process Description:
Stage-1
Stage-2
Stage-3
Stage-2 reacts with Hydrogen in presence of Raney Nickel as catalyst and Toluene
as solvent media to give Stage-3 as product.
Stage-4
Stage-3 reacts with Urea in the presence of Sodium Hydroxide as a solvent media to
give Stage-4 as product.
Stage-5
Stage-6
DOMPERIDONE
Route of synthesis:
Stage-1
O NH2
Raney Nickel +
+ H2 + NH3 H 2O
N N
O O CH3 O O CH3
Cl
NH2
HN
NO2
Cl NO2
1
Methanol
+ + /2 Na2CO3
N
Cl N
O O CH3
O O CH3
Stage-3
Cl
Cl
HN
HN
NH2
NO2
Raney Nickel
+ 3 H2
Toluene N
N
O O CH3
O O CH3
327.76 297.78
+ 2H2O
2X18=36.00
Stage-4
H
Cl Cl N
O
HN N
NH2 O
NaOH
+ N
N H2N NH2
O O CH3
O O CH3
4-(2-Amino-4-chloro-phenylamino) 4-(5-Chloro-2-oxo-2,3-dihydro-
Urea
-piperidine-1-carboxylic acid ethyl ester enzoimidazol-1-yl)-piperidine-1-
CH4N2O carboxylic acid ethyl ester
C14H20ClN3O2
60.05 C15H18ClN3O3
297.78
323.77
+ 2NH3
Ammonia
2X17.03=34.06
Stage-5
Cl H
N
Cl H
O N
N O
N
+ NaOH
N
N
O O CH3 H
+ C2H5ONa + CO2
Stage-6
Cl H
N
O H
N N MIBK
1
O + /2Na2CO3
+
N
Cl
N
H
5-Chloro-1-piperidin-4-yl-1,3 1-(3-chloropropyl)-1,3-dihydro Sodium carbonate
-dihydro-benzoimidazol-2-one -2H-(Benzimidazole-2-one) 1
/2X105.98=52.99
C12H14ClN3O C10H11ClN2O
251.71 210.66
N
N
O 1/ CO
+ 1
N + NaCl /2 H2O + 2 2
N
H O Cl
N
H
425.91
DOMPERIDONE
Flow Chart:
N-Carbethoxy-4-piperidone Product
Ammonia gas Methanol Rec
Methanol Stage-1
Raney Nickel 70.0 Kg
Hydrogen Effluent water
Stage-1 Product
2,5-Dichloro Nitrobenzene Methanol Rec
Stage-2
Sodium Carbonate
95.0 Kg
Methanol
Effluent water
Stage-2 Product
Hydrogen Toluene Rec
Raney Nickel Stage-3
Toluene 75.0 Kg
Effluent water
Stage-3 Product
Urea Ammonia
Stage-4
Sodium Hydroxide (48%) 67.0 Kg
Effluent water
Stage-4 Product
Sodium Hydroxide Carbon Dioxide
Stage-5
45.0 Kg
Effluent water
Stage-5
1-(3-Chloropropyl)-1,3-dihydro Product
2H-benzimedazole-2-one Sodium chloride
Sodium Carbonate Stage-6
50.0 Kg CO2
Methyl Isobutyl Ketone
Effluent water
DOMPERIDONE
DOMPERIDONE
Material Balance:
4. ESCITALOPRAM OXALATE
Process Description:
Stage-1
Stage-2
Stage-1 reacts with HBr in the presence of Toluene as a solvent media to give stage-2
as product.
Stage-3
Stage-2 reacts with MPR as a resoluting agent in the presence of Toluene as a solvent
media to give stage-3 as product.
Stage-4
Stage-5
Stage-6
Stage-5 reacts with Oxalic acid in the presence of Toluene as a solvent media to give
stage-6 as product.
Stage-7
Stage-6 reacts with cuprous cyanide in the presence of Toluene as a solvent media to
give stage-7 as product.
Stage-8
Stage-7 reacts with Oxalic acid in the presence of Toluene as a solvent media to give
Escitalopram Oxalate as product.
ESCITALOPRAM OXALATE
Route of synthesis:
Stage-1:
Br MgBr H3C
N MgCl Toluene
O + + + 3H2O
H3 C
F
O
Br
OH
CH3
OH
N
CH3
+ Mg(Br)OH + Mg(Cl)OH
F
4-Dimethylamino-1-(4-fluoro- Magnesium Magnesium
phenyl)-1-(2-hydroxymethyl- hydroxy bromide hydroxy chloride
phenyl)-butan-1-ol 121.21 76.76
C19H23BrFNO2
396.29
Stage-2:
Br
Br OH
OH CH3
CH3 OH
OH N
N CH3
CH3
Toluene HBr
+ HBr
F
F
Stage-3:
Br
OH H3 C O OH
CH3 O
OH
N O Toluene
CH3 O
+
HBr O
O OH CH3
4-Dimethylamino-1-(4-fluoro- MPR
phenyl)-1-(2-hydroxymethyl- C20H18O8
phenyl)-butan-1-ol Hydrobromide
386.35
C19H23BrFNO2.HBr
477.20
Br
OH
CH3 H3C O OH
OH O
N
CH3 O + HBr
O
O
O OH CH3
F
Hydrobromic acid
1-(4-Bromo-2-hydroxymethyl-phenyl)-4-dimethylamino
-1-(4-fluoro-phenyl)-butan-1-ol with (+)/(-) MPR Salt 80.91
C19H23BrFNO2.C20H18O8
782.64
Stage-4:
Br
OH H3C O OH
CH3 O
OH
N Toluene
CH3 O
O
O
O OH CH3
F
1-(4-Bromo-2-hydroxymethyl-phenyl)-4-dimethylamino
-1-(4-fluoro-phenyl)-butan-1-ol with (+)/(-) MPR Salt
C19H23BrFNO2.C20H18O8
782.64
Br
OH
CH3
OH H3C O OH
N O
CH3
O
+ O
O
O OH CH3
F
1-(4-Bromo-2-hydroxymethyl-phenyl)- MPR
4-dimethylamino-1-(4-fluoro-phenyl)-butan-1-ol
C20H18O8
C19H23BrFNO2 386.35
396.29
Stage-5:
Br Br
OH O CH3
CH3
OH N
N CH3
CH3 Toluene
F
F
1-(4-Bromo-2-hydroxymethyl-phenyl)- {3-[5-Bromo-1-(4-fluoro-phenyl)-1,3-dihydro-
4-dimethylamino-1-(4-fluoro-phenyl)-butan-1-ol isobenzofuran-1-yl]-propyl}-dimethyl-amine
C19H21BrFNO
C19H23BrFNO2
378.27
396.29
+ H2 O
18.00
Stage-6:
Br
O CH3
N O OH
CH3
Toluene
+
HO O
F
Br
O CH3
N
CH3 O OH
HO O
F
{3-[5-Bromo-1-(4-fluoro-phenyl)-1,3-dihydro-isobenzofuran-
1-yl]-propyl}-dimethyl-amine salt of Oxalic acid
C19H21BrFNO.C2H2O4
474.36
Stage-7:
Br
O CH3
N
CH3 O OH Toluene
CuCN
+
HO O
F
NC
O CH3
N O OH
CH3
+ CuBr +
HO O
F
{3-[5-Cyano-1-(4-fluoro-phenyl)-1,3-dihydro- Cuprous bromide Oxalic acid
isobenzofuran-1-yl]-propyl}-dimethyl-amine 90.03
143.45
C20H21FN2O
324.39
Stage-8:
NC
O CH3
N O OH
CH3
Toluene
+
HO O
NC
O CH3
N
CH3 O OH
HO O
F
{3-[5-Cyano-1-(4-fluoro-phenyl)-1,3-dihydro-
isobenzofuran-1-yl]-propyl}-dimethyl-amine salt of Oxalic acid
C20H21FN2O.C2H2O4
414.42
Stage-9
NC
NC
O CH3
O CH3
N
N CH3 O OH
CH3 O OH
IPA
HO O
HO O
F
F
Esitolopram oxalate
Esitolopram oxalate
C20H21FN2O.C2H2O4
C20H21FN2O.C2H2O4
414.42
414.42
ESCITALOPRAM OXALATE
Flow Chart:
Bromophthalide
Fluorobromobenzene
Dimethyl amino propyl Stage-1 Effluent water
magnesium chloride
Magnesium turnings
Stage-1
Hydrobromic acid Toluene Rec
Stage-2 Effluent water
Activated carbon
Toluene
Stage-2
MPR IPA Rec
Activated carbon Stage-3 Toluene Rec
IPA Effluent water
Toluene
Stage-3
Toluene Rec
Sodium hydroxide
Stage-4 Effluent water
Sodium sulfate
Toluene
Stage-4
Methane sulfonyl chloride Acetone Rec
Triethylamine Stage-5 Effluent water
Sodium sulfate
Toluene
Stage-5
Oxalic acid Stage-6 Acetone Rec
Acetone
Stage-6
Sodium hydroxide DMF Rec
Copper cyanide Stage-7 Toluene Rec
Ethylene di amine
DMF
Toluene
IPA Rec
Stage-7 Toluene Rec
Oxalic acid Stage-8
Effluent water
Toluene
IPA
Stage-8
IPA Stage-9 IPA Rec
Activated carbon
ESCITALOPRAM OXALATE
ESCITALOPRAM OXALATE
Material Balance:
Process
Description:
Stage-1
Stag
e-2
Route of synthesis:
Stage-1:
OCH3 CH3
OH
H3C CH3 H3C O
N OCH3
Toluene
N C S + KOH
+
H2
N
H
OCH3
CH3
H3C CH3 H3C OH
O N OCH3
N C S H2O +
H2
N
K+
Stage-2:
OCH3
H3C CH3
O N OCH3
2 N C S H2O + MgSO4 + H2O
H2
N
K+
Esomeprazole potassium salt.Monohydrate Magnesium sulfate 18.00
C17H20KN3O4S 120.36
2X401.52=803.04
OCH3
H3C CH3
O N OCH3 K2SO4
Mg 3H2O +
N C S
H2
N 2
Flow Chart:
Omeprazole sulfide
Cumin hydroperoxide Stage-1 Methanol Rec
Potassium hydroxide
Methanol
Stage-1
Magnesium sulfate Stage-2 Effluent Water
Water
ESOMEPRAZOLE MAGNESIUM
Process Description:
Stage-1
Magnesium metal is charged into a clean and dry reactor under Nitrogen purging,
Charge THF and start stirring. Raise the reactor temperature up to required
temperature. Start and continue the addition of ethyl chloride up to completion of
the reaction. Maintain few hours and cool to room temperature. Check sample and
unload the material into containers under Nitrogen atmosphere.
Route of Synthesis:
Stage-1:
THF
Mg H3C Cl H3C MgCl
+
Flowchart:
Ethyl Chloride
Mg turnings Stage-1 THF Recovery
THF
Material Balance:
7. LINEZOLID
Process Description:
Stage-1:
LINEZOLID
Route of Synthesis:
Stage-1
O
O N NH O
OH
N N N
F
O + NH HN
2-[3-(3-Fluoro-4-morpholin-4-yl-phenylamino) +
-2-hydroxy-propyl]-isoindole-1,3-dione Carbonyl diimidazole
C 7 H 6 N4 O
C21H22 FN3O4
162.15
399.42
O O
O H2 N
H H NH2 MDC
+ O
Hydrazine hydrate Acetic anhydride
H6N2O C4H6O3
50.06
102.09
O
O
O N N H
N CH3 HN
F N
O + 2 + CH3COOH
Linezolid
Imidazole 60.0
C16 H20FN3O4 C 3 H 4 N2
337.35
2X68.08=136.16
OH
N
N
+
+ H2 O
OH
Phthalazine -1,4-diol
18.0
C8H6N2O2
162.15
LINEZOLID
Flow Chart:
N-[3-Phthalimido-2R-hydroxy
propyl-3-fluoro-4-
morpholinyl aniline Stage-1 Methanol Rec
Carbonyl diimidazole
Hydrazine Hydrate
Methanol
LINEZOLID
LINEZOLID
Material Balance:
8. LOPERAMIDE HYDROCHLORIDE
Process Description:
Stage-1:
N-(3,3-diphenyldihydrofuran-2(3H)-ylidene)-N-methylmethanaminium bromide is
reacted with 4-(Chloro phenyl) - Piperidine –4-ol in presence of Potassium
carbonate(K2CO3), Potassium iodide(KI), Potassium hydroxide (KOH) acetone,
Toluene ,HCl & Water to get Stage-1 compound.
Stage-2
Stage I is reacted with Methanolic HCl and then it is purified in presence of Acetone,
Methanol & Activated carbon to get Loperamide HCl (Pharama)
LOPERAMIDE HYDROCHLORIDE
Route of Synthesis
Stage-1:
O
N+ Br- OH Cl
HN 1/2 K2 CO3
+
+
Potassium
N-(3,3-diphenyldihydrofuran- 4-(Chloro phenyl) -
Carboante
2(3H)-ylidene)-N-methylm Piperidine -4-ol
C11H14ClNO 1/2X138.21=69.1
ethanaminium bromide
C18H20BrNO 211.69
346.26
Acetone / KI
OH
N
O Cl
N
Stage-2:
OH
Cl
N
N
O
Methanol
+ HCl
Carbon
OH
Cl
N
N
O Cl
H
4-[4-(4-chlorophenyl)-4-hydroxy
piperidin-1-yl]-N,N-dimethyl-2,2-
diphenylbutanamide Hydrochloride
C29H34Cl2N2O2
513.50
LOPERAMIDE HYDROCHLORIDE
Flow Chart
N-[(2Z)-3-(diphenylmethyl)dihydra
furan-2(3H)-ylidene]methanamine Acetone Rec
4-(Chloro phenyl)-Piperidine-4-ol Stage-1 Effluent water
Potassium carbonate
Acetone
LOPERAMIDE HYDROCHLORIDE
Material Balance
Process Description
Stage-1
2 moles of Methyl Magnesium Chloride in THF are reacted under certain conditions
to form Di methyl Magnesium and Magnesium Chloride.
Stage-2
Route of Synthesis
Stage-1
THF
2 CH3MgCl (CH3)2Mg + MgCl2
Stage-2
CH3
2 H3C OH THF
(CH3)2Mg (C4H9O)2Mg + 2 CH4
+ CH3
Flow Chart
Material Balance:
Process Description
METFORMIN HYDROCHLORIDE
Route of Synthesis:
Stage-1:
CH3
NH
H H
N N N NH2
H CN H3C
H3C CH3 Xylene H
Cl + H2N N
H Cl
NH NH
Dimethyl amine Hydrochloride N-Cyanoguanidine
Metformin Hydrochloride
C2H8NCl C2H4N4 C4H12N5Cl
81.58 84.08 165.66
METFORMIN HYDROCHLORIDE
Flow Chart:
Dimethylamine Hcl
N-Cyano guanidine Xylene Recovery
Stage - 1
Xylene Methanol Recovery
Methanol
Metformin
Hydrochloride
METFORMIN HYDROCHLORIDE
Material Balance:
Process Description
Stage-1
Magnesium metal is charged into a clean and dry reactor under nitrogen purging.
Charge THF and start stirring. Raise the reactor temperature up to required
temperature. Start and continue the addition of methyl chloride up to completion of
the reaction. Maintain for few hours and cool to room temperature. Check Product
and unload the material into the containers under nitrogen atmosphere.
Route of Synthesis
Stage-1
Flow Chart
Magnesium Metal
Methyl Chloride Stage-1 THF Rec
THF
Material Balance:
Process Description
Stage-1
N, N-Dimethyl proyl amino chloride reacts with magnesium in presence of THF and
Toluene by addition of Catalytic amount of Iodine and EDB.
Route of Synthesis
Stage-1
CH3
Cl N CH3
I2 / EDB ClMg N
CH3 + Mg
CH3
THF/Toluene
(3-Chloro-propyl)- 24.31
dimethyl-amine N,N-Dimethyl propyl
C5H12ClN magnesium chloride
C5H12ClMgN
121.61
145.91
Flow Chart
(3-Chloro-propyl)-
dimethyl-amine
Magnesium turnings Stage-1 THF Rec
EDB Toluene Rec
Iodine
THF
Toluene
N, N-DIMETHYL PROPYL MAGNESIUM CHLORIDE
Material Balance:
13. OMEPRAZOLE
Process Description
Stage-1
Stage-2
Above stage compound on reaction with Sodium methoxide, Sodium Hydroxide and
Dimethyl sulphate in Methanol and water produces stage-2 product. Reaction takes
place as per the equation
Stage-3
A Stage-2 product on reaction with Thionyl chloride, APS and sodium hydroxide
produces stage-3 compound. Toluene is the solvent used in the process. Below is
the equation.
Stage-4
OMEPRAZOLE
Route of Synthesis:
Stage-1
NO2
N
Acetic acid N
+ H2O2 + HNO3 + 2H2O
168.15
.Stage-2
NO2
N Methanol
+ CH3ONa + 2NaOH + (CH3)2SO4
O
3,5-Dimethyl-4-nitro Sodium Sodium hydroxide Dimethyl sulfate
-pyridine N-Oxide methoxide
2X40=80.0 126.13
C7H8N2O3
54.02
168.15
COOH
O
3,5-Dimethyl-isonicotinic acid 69.0 18.0 142.04 32.0
N-Oxide
C8H9NO3
167.16
Stage-3
O Cl
COOH
N Toluene N
+ SOCl2 + NH4OH
O O
3,5-Dimethyl-isonicotinic acid Thionyl chloride Ammonium
N-Oxide 3,5-Dimethyl-isonicotinoyl
hydroxide
C8H9NO3 118.97 chloride N-Oxide
35.05 C8H8ClNO2
167.16
185.61
Stage-4
O Cl
H
N
HS + NH4OH Toluene
N + N O
O
2-Mercapto-5-methoxy Ammonium
3,5-Dimethyl-isonicotinoyl
benzimidazole Hydroxide
chloride N-Oxide
C8H8N2OS 35.05
C8H8ClNO2
180.23
185.61
N
O N CH3
S
N H3C + NH4Cl
H OCH3 + H2O
53.49 18.0
5-Methoxy-2-(4-methoxy-3,5-dimethyl-
pyridin-2-ylmethylsulfanyl)-
1H-benzoimidazole
C17H19N3O2S
329.42
Stage-5
N
O N CH3
S
N Methanol
H3 C OCH3 + H2 O 2
H
329.42
H
N
S N
+ H2 O
O N O
Omeprazole 18.0
C17H19N3O3S
345.42
OMEPRAZOLE
Flow Chart:
Product
3,5-Lutidine
Hydrogen Peroxide Stage-1
Acetic acid 47.3 Kg
Effluent water
Stage-1
Product
Sodium methoxide
Methanol Rec
Sodium hydroxide Stage-2
Dimethyl sulphate 42.5 Kg
Methanol
Effluent water
Product
Stage-2
Toluene Rec
Thionyl Chloride Stage-3
Sodium hydroxide 52.40 Kg
Toluene
Effluent water
Stage-3 Product
2-Mercapto-5-methoxy Benzimidazole Toluene Rec
Stage-4
CS Lye 94.0 Kg
Toluene
Effluent water
Stage-4 Product
Hydrogen peroxide Methanol Rec
Stage-5 Acetone Rec
Methanol
100.0 Kg
Acetone
Effluent water
OMEPRAZOLE
OMEPRAZOLE
Material Balance:
PANTOPRAZOLE SODIUM
Route of Synthesis:
Stage-1:
O O
OH OCH3
Acetone
2 + (CH3)2SO4 + K2CO3 2 + K2SO4
O CH3 O CH3
+ CO2 + H2O
44.0 18.0
Stage-2:
O O
OCH3 OCH3
+ (NH4)2CO3 + NH4OH + CO2 + H 2O
O CH3 N CH3
H
3-Methoxy-2-methyl- Ammonium 18.0
3-Methoxy-2-methyl- 35.0 44.0
pyran-4-one carbonate
1H-pyridin-4-one
C7H8O3 96.0 C7H9NO2
140.14 139.15
Stage-3:
O Cl
OCH3 OCH3
MDC
3 + POCl3 3 + H3PO4
N CH3 N CH3
H
4-Chloro-3-methoxy- Phosphoric Acid
3-Methoxy-2-methyl- Phosphorous
2-methyl-pyridine 98.0
1H-pyridin-4-one oxychloride
C7H8ClNO
C7H9NO2 153.33
3X157.60=472.8
3X139.15=417.45
Stage-4:
Cl
Cl OCH3
OCH3
H 2O 2 MeOH N CH3 H 2O
+ +
Acetic acid
N CH3 O
4-Chloro-3-methoxy-2- Hydrogen peroxide 3-methoxy-2-methyl-4- 18.0
methyl-pyridine chloro pyridine-N-oxide
34.01
C7H8ClNO
C7H8ClNO
157.60 173.60
Stage-5:
Cl OCH3
OCH3 OCH3
MeOH
+ CH3ONa + NaCl
N CH3 N CH3
O O
54.02
58.5
3,4-Dimethoxy-2-methyl 3,4-Dimethoxy-2-methyl
pyridine-N-oxide pyridine-N-oxide
C7H8ClNO C8H11NO3
169.18
173.60
Stage-6:
OCH3
OCH3
OCH3
OCH3
MDC
+ (CH3CO)2O + CH3COOH
N CH3 N CH2OCOCH3
O
Acetic acid
Acetic acid 3,4-dimethoxy-
3,4-Dimethoxy-2-methyl Acetic anhydride
pyridin-2-ylmethyl ester 60.0
pyridine-N-oxide C10H13NO4
C8H11NO3
102.09 211.21
169.18
Stage-7
OCH3 OCH3
OCH3 OCH3
MDC CH3COONa
+ NaOH +
N CH2OCOCH3 N CH2OH
Stage-8:
OCH3
OCH3
OCH3
OCH3
MDC,MeOH HCl + SO2
+ SOCl2
N CH2Cl
N CH2OH
Stage-9:
SH
N NH
OCH3
OCH3
O MDC
HCl + + 2 NH4OH
F
N CH2Cl
F
2-Chloromethyl-3,4-dimethoxy- 5-Difluoromethoxy-2- Ammonium
pyridine Hydrochloride mercaptobenzimidazole hydroxide
C8H6F2N2OS 2X35.04=70.08
C8H10ClNO2.HCl
216.21
224.12
OCH3
OCH3
H
N
N CH2 S F
N O 2 H2 O
+ 2 NH4Cl +
F
5-Difluoromethoxy-2-(3,4-dimethoxy- Ammonium chloride 2x18.0=36
pyridin-2-ylmethylsulfanyl)-
1H-benzoimidazole 106.98
C16H15F2N3O3S
367.37
Stage-10:
OCH3
OCH3
H
N
N CH2 S F
N O MDC
+ NaOCl + NaOH
F
Acetone
5-Difluoromethoxy-2-(3,4-dimethoxy- Sodium Sodium
pyridin-2-ylmethylsulfanyl)- hypochlorite hydroxide
1H-benzoimidazole 40.0
C16H15F2N3O3S 74.44
367.37
OCH3
OCH3
O
N
N CH2 S F
N O + NaCl + H 2O
Na F
405.35
PANTOPRAZOLE SODIUM
Flow Chart:
Maltol
Dimethyl sulphate Stage-1 Potassium sulfate
Potassium carbonate
Stage-1
Ammonium
Carbonate Stage-2 Toluene Rec
Toluene
Stage-2
Phosphorous
oxy chloride Stage-3 MDC Rec
MDC
Stage-3
Hydrogen peroxide
Acetic acid Stage-4 Methanol Rec
Methanol
Stage-4
Methanol Stage-5 Methanol Rec
Sodium methoxide
Stage-5
Acetic Anhydride Stage-6 Chloroform rec
Chloroform
Stage-6
Sodium hydroxide Stage-7 MDC Rec
MDC
Stage-7
Thionyl chloride
chloroform Stage-8 Chloroform Rec
Stage-8
5-diFluoromethoxy
-2-mercapto- Stage-9 Sodium chloride
benzimidazole
Stage-9
Sodium
hypochlorite Stage-10 Sodium chloride
Sodium
Hydroxide
PANTOPRAZOLE SODIUM
PANTOPRAZOLE SODIUM
Material Balance:
Process Description
Stage-1
Magnesium metal is charged into a clean and dry reactor under nitrogen purging.
Charge THF and start stirring. Raise the reactor temperature up to required
temperature. Start and continue the addition of Chlorobenzene up to completion of
the reaction. Maintain for few hours and cool to room temperature. Check Product
and unload the material into the containers under nitrogen atmosphere.
Route of Synthesis:
Stage-1:
Cl MgCl
THF
Mg +
Flow Chart:
Chlorobenzene
Stage-1 THF Recovery
Magnesium turnings
THF
Material Balance:
Process Description:
Stage-1
Stage-2
Stage-3
Stage-2 compound made to react with Piperazine in Toluene medium to produce the
stage -3 compound.
Stage-4
Stage-3 is converted to pharma by treating with Chloro ethoxy ethanol and Fumaric
acid in Toluene medium. Toluene layer is washed with water to remove water
soluble impurities. Finally the pharma is re-crystallized in Methanol.
QUETIAPINE FUMARATE
Route of synthesis:
Stage-1:
-O O
O
Cl
O S O
O Toluene
+ -O O
NH2
2-Aminodiphenyl sulphate Phenyl chloro fumarate
C12H11NO4S C10H5ClO4
224.60
265.29
NH O O Cl
S
OH + CO2
+ HO O
Stage-2:
O
OH
NH O HN
S
Phosphoric acid
+ H2 S
Dibenzo,1,4-thiozepin,1-H-one
Phenyl-2-(phenyl carbamate Hydrogen
C13H11NOS
C19H15NO2S 2.00
229.30
321.39
OH
Phenol
C6H6O
94.11
Stage-3:
NH
OH
HN H N
N
Toluene
+ HN NH
S + H 2O
S
Stage-4:
Step-A
NH
H N
N
O Toluene
S + HO Cl
11-Piperazin-1-yl-5a,9a,10,11 2-(2-Chloro-ethoxy)-ethanol
-tetrahydro-dibenzo[b,f] C4H9ClO2
[1,4]thiazepine
C17H19N3S 124.57
297.42
O
N Cl
H N
N
+ H2 O
S
11-{4-[2-(2-Chloro-ethoxy)-ethyl]-piperazin 18.00
-1-yl}-10,11-dihydro-dibenzo[b,f]
[1,4]thiazepine
C21H26ClN3OS
403.97
Step-B
O
N
Cl O OH
H N
N
+ HO O
S
Fumaric acid
11-{4-[2-(2-Chloro-ethoxy)-ethyl]-piperazin
-1-yl}-10,11-dihydro-dibenzo[b,f] C4H4O4
[1,4]thiazepine
C21H26ClN3OS 116.07
403.97
Toluene
O
N OH
O Cl
H N
N +
HO O
S
Step-C
O
N OH
H N O OH
N
S
+ HO O
2
Fumaric acid
Quetiapine
C42H50N6O4S2 C 4 H4 O 4
2X385.52=770.00 116.07
O
N OH
N O OH
H
N
S HO O
2
Quetiapine fumarate
C46H54N6O8S2
886.07
QUETIAPINE FUMARATE
Flow Chart:
2-Aminbiphenylsulphate
Phenyl chloro fumarate Stage-1 Toluene Rec
Toluene
Stage-1
phosphoric acid Stage-2 Acetone Rec
Acetone
Stage-2
Piperazine Stage-3 Toluene Rec
Toluene
Stage-3
Chloro ethoxy ethanol Stage-4 Methanol Rec
Fumaric acid
Methanol.
QUETIAPINE FUMARATE
QUETIAPINE FUMARATE
Material Balance:
Process Description
Stage-1
Stage-2
Stage-3
Stage-4
Stage-5
Stage-6
RABEPRAZOLE SODIUM
Route of Synthesis:
Stage-1:
NO2
CH3 CH3
H2SO4 2H2O
H2O2 + +
+ HNO3
N CH3 N CH3
O
2,3-Lutidine Hydrogen 4-Nitro-2,3-Dimethyl
Niric acid pyridine-N-oxide 36.0
C7H9N peroxide
34.01 63.0 C7H8N2O3
107.15
168.15
Stage-2:
O O
NO2
H3C
CH3
+ HO O + NaOH H3C N+
N CH3
O-
O
4-Nitro-2,3-Dimethyl 3-Methoxy-1-Propanol 4(3-Methoxy propoxy)-2,3-
40.0
pyridine-N-oxide C4H10O2 Dimethyl pyridine-N-oxide
C7H8N2O3 90.12 C11H17NO3
168.15 211.26
+ NaNO2 + H2 O
Stage-3:
O O
H 3C
(CH3CO)2O + HCl
+ NaOH
H3C N+ +
36.5
O- 40.0
4(3-Methoxy propoxy)-2,3 Acetic Anhydride
-Dimethyl pyridine-N-oxide 102.0
C11H17NO3
211.26
O O
Cl
H CH3COONa + CH3COOH
HO +
N
82.0 60.0
4(3-methoxy propoxy)-2-hydroxy
methyl -3-methyl pyridine
hydrochloride
C11H17NO3 HCl
247.72
Stage-4:
O O O O
Cl
+ SO2
H + SOCl2 Cl
HO N
N 64.0
Thionyl 4-(3-methoxy-propoxy)-2-
4(3-methoxy propoxy)-2-hydroxy
Chloride Chloromethyl-3-methyl-
methyl -3-methyl pyridine
Pyridine
hydrochloride 118.97 C11H16ClNO2
C11H17NO3 HCl
247.72 229.7
+ 2 HCl
2X36.5=73
Stage-5:
O O
H
N
Cl + HS + NH4OH
N N
O O
N
S C N
N H2 + NH4Cl + H2 O
H
2-[4-(3-Methoxy-propoxy)-3-methyl-pyridin- 53.49 18.0
2-ylmethylsulfanyl]-1H-benzoimidazole
C18H21N3O2S
343.44
Stage-6:
O O
O O
O
N
N
NaOCl S C N
S C N + H2
N H2 N
H H
+ NaCl
58.5
Stage-7:
O O O O
O O
N N
S C N + NaOH S CH N + H 2O
N H2 N
H H Na
RABEPRAZOLE SODIUM
Flow Chart:
2,3 Lutidine
Hydrogen peroxide Stage-1 Generated water
Nitric acid
Stage-1
3-Methoxy-1-propanol Stage-2 Sodium nitrite
Sodium hydroxide
RABEPRAZOLE SODIUM
RABEPRAZOLE SODIUM
Material Balance:
Process Description
Stage-1
SODIUM METHOXIDE
Route of Synthesis
Stage-1
SODIUM METHOXIDE
Flow Chart
SODIUM METHOXIDE
SODIUM METHOXIDE
Material Balance:
Process Description
Stage-1
Sodium is added into excess tert-butanol in a rotary drier cum reactor. Excess Tert-
Butanol is used to ensure the complete reaction of the corresponding metals. Then
the excess Tert-Butanol is recovered by thermic fluid heating through a condensor
and used again in the next batches. A small quantity of hydrogen is let out through a
liquid paraffin trap.
Route of Synthesis
Stage-1:
CH3 CH3
CH3 CH3
Flow Chart:
Material Balance:
20. TELMISARTAN
Process Description
Stage-1
Step-A
Methyl-4-(butyramido)3-methyl-5-nitrobenzoate undergoes hydrogenation in the
presence of Palladium carbon as catalyst by using Methanol as solvent media to
give Stage-1A as product.
Step-B
Stage-1A product reacts with sodium hydroxide and hydrochloric acid to give Stage-
1B as product.
Stage-2
Stage-3
Stage-4
Stage-2 product reacts with Stage-3 and potassium hydroxide in the presence of
acetone as solvent media to give Stage-4 as product.
Stage-5
Stage-4 product reacts with potassium hydroxide and hydrochloric acid in the
presence of MDC as solvent media to give stage-5 as product.
Stage-6
Stage-5 product undergoes purification with Methanolic ammonia, acetic acid and
activated carbon in the presence of methanol as solvent media to give Telmisartan
as product.
TELMISARTAN
Route of Synthesis:
Stage-1
Step-A
NH NH
Pd/C
O + H2 H3CO O + O2
H3 CO NH2
NO2 MeOH
O O
methyl-4-(buytramido)-3-methyl Hydrogen Methyl-3-amino-4-(buytramido) Oxygen
-5-nitrobenzoate 2.0 -5-methylbenzoate
C13H16N2O5 C13H18N2O3 32.0
280.28 250.29
Step-B
NH
O + NaOH + HCl
H3CO
NH2
O
Methyl-3-amino-4-(buytramido) Sodium Hydrochloric
-5-methylbenzoate hydroxide acid
C13H18N2O3 40.0 36.5
250.29
OH
N
H + CH3OH + NaCl + H2O
O
Stage-2
N
N NH
PPA N
OH + NaOH N
N
H NH2 N
O H
7-Methyl-2-propyl-3H-benzoimidazole- N-Methylbenzene- 4-Methyl-6-(1-methyl-1H-benzoimidazol
5-carboxylic acid 1,2-diamine -2-yl)-2-propyl-1H-benzo imidazole
C12H14N2O 2 C7H10N2
C19H20N4
218.25 122.17
304.39
+ 2H2O
36.0
Stage-3
H3C O
COOCH3 BrH2C
COOCH3
Br N Chloroform
+
N
Br
O
methyl-4-methyl-1,1-biphenyl- 1,3-Dibromo-5,5-dimethyl
2-carboxylate 4-(bromomethyl)biphenyl-2-
imidazolidine-2,4-dione
C15H14O2 carboxylic acid methyl ester
C5H6N2O2 C15H13 BrO2
226.27 285.92 305.17
+
HN
N
Br
O
1-Bromo-5,5-dimethyl
imidazolidine-2,4-dione
C5H7BrN2O2
207.03
Stage-4
N BrH2C
COOCH3
N
N + Acetone
+ KOH
N
H
N
N
N
+ KBr + H2O
COOCH3
Stage-5
N
N
N
MeOH
+ KOH + HCl
COOCH3
N
N
+ CH3 OH + KCl
N
COOH
Stage-6
N
N
N
MeOH
+ CH3OH NH3 + CH3COOH
COOH
514.62 49.07
N
N
N
+ CH3COONH4 + CH3OH
COOH
TELMISARTAN
Flow chart:
Methyl-4-(butyramido)-3- Product
methyl-5-nitrobenzene Methanol Rec
Methanol Stage-1
Palladium carbon(Wet 5% MC) 55.0 Kg
Sodium hydroxide Effluent water
Hydrochloric acid
Stage-1 Product
N-Methylbenzene-1,2-diamine Stage-2
Poly phosphoric acid 73.0 Kg
Sodium hydroxide
Effluent water
Methyl-4-methyl-1,1-biphenyl-
2-carboxylate Product
1,3-dibromo-5,5-dimethyl n-Hexane Rec
Stage-3
imidazolidine-2,4-dione
Sodium meta bisulphate 73.50 Kg
Chloroform Effluent water
n-Hexane
Product
Stage-2 Acetone Rec
Stage-4
Stage-3 123.0 Kg
Potassium hydroxide
Acetone Effluent water
Stage-4 Product
Potassium hydroxide Carbon Dioxide
Stage-5
MDC 115.0 Kg
Methanol
Hydrochloric acid (20%) Effluent water
Stage-5 Product
Methanolic ammonia Methanol Rec
Stage-6
Acetic acid
100.0 Kg
Methanol
Effluent water
TELMISARTAN
TELMISARTAN
Material Balance:
Annexure - III
Water
S. No Purpose Requirement
In KLD
1 Process 49.82
2 Washings 2.00
3 Boiler Make up 58.50
4 Cooling towers Make up 144.50
5 DM Plant 2.00
6 Scrubbing system 2.00
7 Domestic usage 2.00
8 Gardening 5.00
Total 266.0
Annexure - IV
Annexure - V
Annexure - VI
Quantity
S. No Name of the Gas In Treatment Method
Kg/Day
Polluting Process Emission Details
1 Ammonia 95.00 Scrubbed by using chilled water media
2 Sulphur dioxide 248.00 Scrubbed by using C. S. Lye solution
Non- Polluting Process Emission Details
1 Carbon dioxide 150.00 Dispersed into atmosphere
2 Oxygen 8.00 Dispersed into atmosphere
30.00 Diffused by using Nitrogen through
3 Hydrogen
Flame arrestor
103.00 Dispersed into atmosphere through
4 Methane
Nitrogen
Annexure - VII
3. DOMPERIDONE
4. ESCITALOPRAM OXALATE
7. LINEZOLID
8. LOPERAMIDE HYDROCHLORIDE
13. OMEPRAZOLE
20. TELMISARTAN
Annexure - VIII
LIST OF BY -PRODUCTS
Annexure - IX
S. No Purpose Effluent
In KLD
1 Process 52.39
2 Washings 2.00
3 Boiler Blow down 8.50
4 Cooling towers Blow down 26.00
5 DM Plant Regeneration 2.00
6 Scrubbing system 2.00
7 Domestic 2.00
Total 95.00